September 2026
The U.S. pharmaceutical CDMO market size was calculated at USD 46.55 billion in 2026 and is predicted to reach around USD 83.25 billion by 2034, with a CAGR of 7.47%.
September 2026
The U.S. pharmaceutical market was valued at USD 552.72 billion in 2026, with leading companies including Johnson & Johnson, Pfizer, Merck & Co., AbbVie, Bristol Myers Squibb, Eli Lilly.
September 2026
The active pharmaceutical ingredients CDMO market reached USD 125.99 billion in 2026, with key active pharmaceutical ingredients CDMO market companies including Lonza, Thermo Fisher Scientific.
September 2026
Europe Pharmaceutical CDMO market size is projected to hit around USD 94.94 billion by 2035, rising from USD 49.06 billion in 2026, growing at a CAGR of 7.59%.
September 2026
The U.S active pharmaceutical ingredients market size stood at USD 44.46 billion in 2026, with major U.S active pharmaceutical ingredients market companies including AbbVie Inc, Viatris Inc, Fresenius Kabi AG.
September 2026
The U.S. pharmaceutical water market was valued at USD 8.66 billion in 2026, with leading companies including Veolia Water Technologies, Thermo Fisher Scientific, Danaher Corporation, Merck KGaA.
September 2026
The U.S. radiopharmaceutical therapies market size is estimated to hit around USD 7.70 billion by 2035 increasing from USD 1.92 billion in 2025, with a CAGR of 14.9%%.
June 2026
The global pharmaceutical CDMO for formulations market size is accounted to hit around USD 103.33 billion by 2035, increasing from USD 52.56 billion in 2026, with a CAGR of 7.78%.
March 2026
The global pharmaceutical CDMO market size is calculated at USD 197.40 billion in 2025 and is projected to hit around USD 392.67 billion by 2035 with a CAGR of 7.12%.
January 2026
The global radiopharmaceutical CDMO market size was evaluated at USD 3.24 billion in 2025 and is predicted to hit around USD 8.50 billion by 2035, growing at a CAGR of 10.12%.
September 2026
The global vaccine CDMO market size was evaluated at USD 5.56 billion in 2026 and is predicted to hit around USD 11.16 billion by 2034, growing at a CAGR of 9.10%.
September 2026
The high-potency API (HPAPI) CDMO market is expanding with rising demand for oncology drugs, targeted therapies, and advanced containment solutions.
September 2026
The U.S. dental equipment market reached USD 3.48 billion in 2026, with prominent companies such as U.S. dental equipment market leading the Midmark Corporation, Takara Belmont Corporation, Ultradent Products Inc., Millennium Dental Technologies.
September 2026
The oncology CDMO market is expanding rapidly, fueled by rising cancer prevalence, growing demand for advanced therapies like ADCs and cell & gene therapies, and the increasing need for specialized outsourcing services.
September 2026
The LNP CDMO market reached USD 271.03 million in 2026, featuring leading LNP CDMO market companies such as Lonza Group, WuXi AppTec, Samsung Biologics.
September 2026
The rare disease small-batch CDMO market is expanding with demand for specialized manufacturing of orphan drugs and niche therapies.
September 2026
The U.S. AI materials product optimization market expands with innovations in computational modeling, automated labs, and AI-driven material design.
September 2026
The U.S. cellulose acetate market size stood at USD 1.84 billion in 2026, with major U.S. cellulose acetate market companies including Eastman Chemical Company, Celanese Corporation.
September 2026
The global pharmaceutical and biotechnology analytics market grows with rising adoption of AI, big data, and cloud tools to accelerate research, R&D, and clinical insights.
September 2026
The global personal care CMO and CDMO market size reached USD 30.78 billion in 2026 and is projected to surpass around USD 44.86 billion by 2034 with a CAGR of 4.82%.
September 2026
The U.S. retail clinics market size reached USD 4.52 billion in 2026 and is projected to hit around USD 9.05 billion by 2035, growing at a notable CAGR of 8.03%.
September 2026
The U.S. dietary supplements market size was valued at USD 85.4 billion in 2026 and is expected to hit around USD 190.08 billion by 2035, with a CAGR of 9.29%.
September 2026
The pharmaceutical quality management software market reached USD 2.66 billion in 2026, featuring leading pharmaceutical quality management software market companies such as IQVIA, Honeywell International Inc.
September 2026
The global pharmaceutical packaging testing market expands as pharma firms adopt advanced testing to ensure product safety, durability, and compliance.
September 2026
The U.S. AI-RAN (artificial intelligence-powered radio access network) market size was evaluated at USD 1.06 billion in 2026 and is predicted to hit around USD 10.53 billion by 2035, growing at a CAGR of 29.08%.
September 2026
The U.S. tuberculosis diagnostics market size was evaluated at USD 607.50 million in 2026 and is predicted to hit around USD 968.67 million by 2035, growing at a CAGR of 5.34%.
September 2026
The global pharmaceutical grade sodium chloride market size is estimated to hit around USD 6.39 billion by 2035 increasing from USD 4.87 billion in 2026, with a CAGR of 3.08%.
September 2026
The global pharmaceutical CRO market size was evaluated at USD 51.44 billion in 2026 and is projected to attain around USD 91.20 billion by 2034, with a CAGR of 7.42%.
September 2026
The contract pharmaceutical fermentation services market size stood at USD 17.46 billion in 2026, with major contract pharmaceutical fermentation services market companies including Catalent, Inc., Thermo Fisher Scientific.
September 2026
The pharmaceutical Inspection Machines Market size totalled USD 1.30 billion in 2026, with major pharmaceutical Inspection Machines Market players including ACG Worldwide, Brevetti C.E.A. S.p.A.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com